Insider linked to AAMI (AAMI) plans sale of 9,691 common shares
Filing Impact
Filing Sentiment
Form Type
144
Rhea-AI Filing Summary
AAMI has a Form 144 notice covering a planned sale of 9,691 shares of its common stock through Citigroup Global Markets on or about 02/09/2026 on the NYSE. The aggregate market value listed for this potential sale is $496,329.00, with 35,709,120 shares of common stock shown as outstanding.
The seller acquired 5,254 shares as retained share compensation on 06/23/2021 and 4,437 shares as retained share compensation on 05/15/2025, both from Acadian Asset Management Inc. By signing the notice, the seller represents that they are not aware of undisclosed material adverse information about AAMI’s operations.
Positive
- None.
Negative
- None.
FAQ
What does the Form 144 filing for AAMI disclose?
The Form 144 for AAMI discloses a proposed sale of 9,691 common shares with an aggregate market value of $496,329.00. The shares are expected to be sold on the NYSE through Citigroup Global Markets on or about February 9, 2026.
What representations does the seller make in the AAMI Form 144?
By signing, the seller represents that they do not know any material adverse information about AAMI’s current or prospective operations that has not been publicly disclosed. The language also references possible use of written trading plans under Rule 10b5-1.